Genomic Precision

 A SeraCare blog focused on precision medicine and advanced clinical diagnostics

New Podcast: Target the Tumor Mutational Burden and Pursue Harmonization

A Featured Speaker Podcast by Friends of Cancer Research

Posted by Melinda Fayette on Mar 20, 2019 10:00:00 AM

Friends of Cancer Research aims to better understand the impact of assay variation on clinical outcomes, align standards, and define best practices for tumor mutational burden assessment. Harmonization of methods to quantify TMB will facilitate robust biomarker development and optimize clinical utilization and treatment decision-making. 

Listen as Dr. Mark Stewart discusses the role of the TMB in cancer research and the need for harmonization throughout the process. 

New call-to-action

Mark Stewart FOCRFeatured Speaker: Mark Stewart, Friends of Cancer Research

Mark leads Friends’ research and policy agenda and oversees research projects. He also establishes partnerships to develop policy proposals and consensus-driven solutions, and accelerate drug development. Mark received his PhD in cancer biology from the University of Alabama at Birmingham.

Topics: TMB, Friends of Cancer Research, tumor mutational burden

 
 
ebook CTA image square Jan2019

Subscribe for Updates

Recent Posts

Categories

see all